Stock A288330 BRIDGE BIOTHERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company Bridge Biotherapeutics, Inc.

Equities

A288330

KR7288330004

Biotechnology & Medical Research

End-of-day quote Korea S.E.
Other stock markets
 23:00:00 16/05/2024 BST 		5-day change 1st Jan Change
2,220 KRW +1.60% Intraday chart for Bridge Biotherapeutics, Inc. -3.48% -32.42%
03-28 Bridge Biotherapeutics Launches Research Collaboration with Emory University School of Medicine to Explore Combination Therapy of BBT-877 for KRAS/P53 Mutant NSCLC Patients Resistant to Anti-PD-1 Blockade CI
03-26 Bridge Biotherapeutics Announces Research Collaboration with the University of Colorado School of Medicine to Explore Potential of BBT-877 for Immuno-Oncology CI

Business Summary

Bridge Biotherapeutics, Inc. is a Korea-based company principally engaged in the research and development of bio therapeutic drugs. The products mainly consist of ulcerative colitis medicine BBT-401, autoxin inhibitor BBT-877, non-small cell lung cancer medicine BBT-176, and others. The Company is also involved in the manufacture of basic pharmaceuticals and biologicals.

Number of employees: 43

Sales per Business

KRW in Million2022Weight2023Weight Delta
Pharmaceutical
100.0 %
- - 100 100.0 % -

Sales per region

KRW in Million2022Weight2023Weight Delta
South Korea
100.0 %
3,024 100.0 % 100 100.0 % -96.69%

Managers

Managers TitleAgeSince
Jeong-Gyu Lee FOU
 Founder 56 16/09/15
Sujin Jung COO
 Chief Operating Officer - -
Sang-Wook Kang CTO
 Chief Tech/Sci/R&D Officer 53 -

Members of the board

Members of the board TitleAgeSince
Seung-Yeob Baek BRD
 Director/Board Member 64 -
Seung-Hoon Lee BRD
 Director/Board Member 62 -
Jeong-Gyu Lee FOU
 Founder 56 16/09/15
Ju-Yeol Yoo BRD
 Director/Board Member 55 -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 24,352,648 19,113,793 ( 78.49 %) 0 78.49 %

Shareholders

NameEquities%Valuation
Jeong-Gyu Lee
14.67 %
3,577,478 14.67 % 6 M ₩
UTC Investment Co., Ltd.
7.042 %
1,717,116 7.042 % 3 M ₩
Hae-seon Choi
5.281 %
1,287,779 5.281 % 2 M ₩
SV Investment Co ltd(Venture Capital)
5.201 %
1,268,289 5.201 % 2 M ₩
Bridge Biotherapeutics, Inc. ESOA
1.356 %
330,650 1.356 % 557 423 ₩
DAEWOONG CO., LTD.
1.010 %
246,240 1.010 % 415 121 ₩
Jong-Jin Lim
0.2064 %
50,326 0.2064 % 84 842 ₩
Byong Kim
0.0820 %
20,000 0.0820 % 33 717 ₩
DFA Australia Ltd.
0.004040 %
985 0.004040 % 1 661 ₩

Company contact information

Bridge Biotherapeutics, Inc.

58 Pangyo-ro 255beon-gil Bundang-gu

13486, Seongnam-si

+

http://www.bridgebiorx.com
address Bridge Biotherapeutics, Inc.(A288330)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Bio Therapeutic Drugs

Annual profits - Rate of surprise

Company calendar

Sector Bio Therapeutic Drugs

1st Jan change Capi.
BRIDGE BIOTHERAPEUTICS, INC. Stock Bridge Biotherapeutics, Inc.
-32.42% 39.55M
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
+9.42% 114B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+11.84% 104B
BIONTECH SE Stock BioNTech SE
-14.15% 22.41B
ARGENX SE Stock argenx SE
-1.05% 22.28B
GENMAB A/S Stock Genmab A/S
-5.29% 19.07B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-38.29% 18B
BEIGENE, LTD. Stock BeiGene, Ltd.
-4.16% 17.89B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+7.99% 14.28B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+36.24% 12.55B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. A288330 Stock
  4. Company Bridge Biotherapeutics, Inc.